Compared with the normal liver tissues, there was a significantly increased expression of PD-L2 (PDCD1LG2), CTLA4, HAVCR2, PDCD1, TIGIT and Siglec-15 in HCC patients, (Fig. 8A). Here, PDCD1 is linked to hepatocellular carcinoma.